British Journal of Cancer - Table of Contents alert Volume 109 Issue 3

TABLE OF CONTENTS Volume 109, Issue 3 (529-826) Published online 6 August 2013 In this issue Editorial Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement Join the EpiRevolution EpiCongress brings together industry experts and renowned academics to reveal the epigenetics secrets of the last 12 months. Hear about the studies that are breaking new ground in the field, including HMT, demethylases, bromodomains and 2nd generation HDAC compounds. Bring the next big thing back to your lab. EpiCongress London - 19 November 2013   Editorial Top Cancer and systemic inflammation: stage the tumour and stage the host D C McMillan Br J Cancer 2013 109: 529; 10.1038/bjc.2013.418 Full Text Minireview Top Molecular sputum analysis for the diagnosis of lung cancer A J Hubers, C F M Prinsen, G Sozzi, B I Witte and E Thunnissen Br J Cancer 2013 109: 530-537; advance online publication, July 18, 2013; 10.1038/bjc.2013.393 Abstract | Full Text Clinical Studies Top Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer M Nishio, T Horai, A Horiike, H Nokihara, N Yamamoto, T Takahashi, H Murakami, N Yamamoto, F Koizumi, K Nishio, W Yusa, N Koyama and T Tamura Br J Cancer 2013 109: 538-544; advance online publication, July 16, 2013; 10.1038/bjc.2013.374 Abstract | Full Text Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809 S Niho, N Ikeda, H Michimae, K Suzuki, H Sakai, T Kaburagi, K Minato, T Kato, H Okamoto, T Seto, Y Hosomi, K Shimizu, F Oshita, H Kunitoh, M Tsuboi, M Takeuchi and K Watanabe Br J Cancer 2013 109: 545-551; advance online publication, July 18, 2013; 10.1038/bjc.2013.378 Abstract | Full Text Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma G L Ceresoli, P A Zucali, M Mencoboni, M Botta, F Grossi, D Cortinovis, N Zilembo, C Ripa, M Tiseo, A G Favaretto, H Soto-Parra, F De Vincenzo, A Bruzzone, E Lorenzi, L Gianoncelli, B Ercoli, L Giordano and A Santoro Br J Cancer 2013 109: 552-558; advance online publication, July 16, 2013; 10.1038/bjc.2013.368 Abstract | Full Text KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases A Zebary, M Jangard, K Omholt, B Ragnarsson-Olding and J Hansson Br J Cancer 2013 109: 559-564; advance online publication, July 16, 2013; 10.1038/bjc.2013.373 Abstract | Full Text Sequelae and survivorship in patients treated with 131I-MIBG therapy W C C Sze, A B Grossman, I Goddard, D Amendra, S C C Shieh, P N Plowman, W M Drake, S A Akker and M R Druce Br J Cancer 2013 109: 565-572; advance online publication, July 16, 2013; 10.1038/bjc.2013.365 Abstract | Full Text Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma Q Wang, M I Fiel, S Blank, W Luan, H Kadri, K W Kim, F Manizate, A G Rosenblatt, D M Labow, M E Schwartz and S P Hiotis Br J Cancer 2013 109: 573-581; advance online publication, July 11, 2013; 10.1038/bjc.2013.352 Abstract | Full Text Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial H Yang, X Zong, Y Yu, G Shao, L Zhang, C Qian, Y Bian, X Xu, W Sun, X Meng, X Ding, D Chen, D Zou, S Xie, Y Zheng, J Zhang, X He, C Sun, X Yu and J Ni Br J Cancer 2013 109: 582-588; advance online publication, July 16, 2013; 10.1038/bjc.2013.324 Abstract | Full Text The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial M Gnant, G Pfeiler, H Stöger, B Mlineritsch, F Fitzal, M Balic, W Kwasny, M Seifert, M Stierer, P Dubsky, R Greil, G Steger, H Samonigg, C Fesl and R Jakesz on behalf of the Austrian Breast and Colorectal Cancer Study Group Br J Cancer 2013 109: 589-596; advance online publication, July 18, 2013; 10.1038/bjc.2013.367 Abstract | Full Text A randomised trial of weekend and evening breast screening appointments J Offman, M Wilson, M Lamont, H Birke, E Kutt, S Marriage, Y Loughrey, S Hudson, A Hartley, J Smith, B Eckersley, F Dungey, D Parmar, J Patnick and S W Duffy Br J Cancer 2013 109: 597-602; advance online publication, July 18, 2013; 10.1038/bjc.2013.377 Abstract | Full Text Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity I Otsuka, S Kameda and K Hoshi Br J Cancer 2013 109: 603-609; advance online publication, July 18, 2013; 10.1038/bjc.2013.402 Abstract | Full Text Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer C Grimm, G Hofstetter, S Aust, I Mutz-Dehbalaie, M Bruch, G Heinze, J Rahhal-Schupp, A Reinthaller, N Concin and S Polterauer Br J Cancer 2013 109: 610-614; advance online publication, July 16, 2013; 10.1038/bjc.2013.323 Abstract | Full Text Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique K Downey, M Jafar, A D Attygalle, S Hazell, V A Morgan, S L Giles, M A Schmidt, T E J Ind, J H Shepherd and N M deSouza Br J Cancer 2013 109: 615-622; advance online publication, July 18, 2013; 10.1038/bjc.2013.375 Abstract | Full Text Patient-reporting improves estimates of postoperative complication rates: a prospective cohort study in gynaecological oncology R Iyer, A Gentry-Maharaj, A Nordin, R Liston, M Burnell, N Das, R Desai, R Gornall, A Beardmore-Gray, K Hillaby, S Leeson, A Linder, A Lopes, D Meechan, T Mould, J Nevin, A Olaitan, B Rufford, A Ryan, S Shanbhag, A Thackeray, N Wood, K Reynolds and U Menon Br J Cancer 2013 109: 623-632; advance online publication, July 11, 2013; 10.1038/bjc.2013.366 Abstract | Full Text Patients’ and urologists’ preferences for prostate cancer treatment: a discrete choice experiment E W de Bekker-Grob, M C J Bliemer, B Donkers, M-L Essink-Bot, I J Korfage, M J Roobol, C H Bangma and E W Steyerberg Br J Cancer 2013 109: 633-640; advance online publication, July 16, 2013; 10.1038/bjc.2013.370 Abstract | Full Text Circulating microRNAs predict biochemical recurrence in prostate cancer patients L A Selth, S L Townley, A G Bert, P D Stricker, P D Sutherland, L G Horvath, G J Goodall, L M Butler and W D Tilley on behalf of the Australian Prostate Cancer BioResource Br J Cancer 2013 109: 641-650; advance online publication, July 11, 2013; 10.1038/bjc.2013.369 Abstract | Full Text Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up A Creak, E Hall, A Horwich, R Eeles, V Khoo, R Huddart, C Parker, C Griffin, M Bidmead, J Warrington and D Dearnaley Br J Cancer 2013 109: 651-657; advance online publication, July 23, 2013; 10.1038/bjc.2013.394 Abstract | Full Text Translational Therapeutics Top Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging L Liebsch, S Kailayangiri, L Beck, B Altvater, R Koch, C Dierkes, M Hotfilder, N Nagelmann, C Faber, H Kooijman, J Ring, V Vieth and C Rossig Br J Cancer 2013 109: 658-666; advance online publication, July 9, 2013; 10.1038/bjc.2013.356 Abstract | Full Text Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model J J Arcaroli, K S Quackenbush, A Purkey, R W Powell, T M Pitts, S Bagby, A C Tan, B Cross, K McPhillips, E-K Song, W M Tai, R A Winn, K Bikkavilli, M VanScoyk, S G Eckhardt and W A Messersmith Br J Cancer 2013 109: 667-675; advance online publication, July 18, 2013; 10.1038/bjc.2013.361 Abstract | Full Text Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors J Moreaux, T Reme, W Leonard, J-L Veyrune, G Requirand, H Goldschmidt, D Hose and B Klein Br J Cancer 2013 109: 676-685; advance online publication, July 18, 2013; 10.1038/bjc.2013.392 Abstract | Full Text Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer R Rosa, V Damiano, L Nappi, L Formisano, F Massari, A Scarpa, G Martignoni, R Bianco and G Tortora Br J Cancer 2013 109: 686-693; advance online publication, July 9, 2013; 10.1038/bjc.2013.360 Abstract | Full Text Molecular Diagnostics Top Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer P A Eisenach, E Soeth, C Röder, G Klöppel, J Tepel, H Kalthoff and B Sipos Br J Cancer 2013 109: 694-703; advance online publication, July 9, 2013; 10.1038/bjc.2013.363 Abstract | Full Text Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers S Attarha, S Andersson, M Mints and S Souchelnytskyi Br J Cancer 2013 109: 704-713; advance online publication, July 9, 2013; 10.1038/bjc.2013.359 Abstract | Full Text MicroRNA profiles classify papillary renal cell carcinoma subtypes S Wach, E Nolte, A Theil, C Stöhr, T T Rau, A Hartmann, A Ekici, B Keck, H Taubert and B Wullich Br J Cancer 2013 109: 714-722; advance online publication, June 25, 2013; 10.1038/bjc.2013.313 Abstract | Full Text Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity D Min, X-b Lv, X Wang, B Zhang, W Meng, F Yu and H Hu Br J Cancer 2013 109: 723-730; advance online publication, July 2, 2013; 10.1038/bjc.2013.337 Abstract | Full Text STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells H-Y Lin, C-H Chiang and W-C Hung Br J Cancer 2013 109: 731-738; advance online publication, July 2, 2013; 10.1038/bjc.2013.349 Abstract | Full Text Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma S Kondo, H Ueno, H Hosoi, J Hashimoto, C Morizane, F Koizumi, K Tamura and T Okusaka Br J Cancer 2013 109: 739-746; advance online publication, July 4, 2013; 10.1038/bjc.2013.348 Abstract | Full Text Epidemiology Top Pigmentation-related phenotypes and risk of prostate cancer S J Weinstein, J Virtamo and D Albanes Br J Cancer 2013 109: 747-750; advance online publication, July 16, 2013; 10.1038/bjc.2013.385 Abstract | Full Text Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women’s Health Study X Ma, A Beeghly-Fadiel, X-O Shu, H Li, G Yang, Y-T Gao and W Zheng Br J Cancer 2013 109: 751-755; advance online publication, July 16, 2013; 10.1038/bjc.2013.384 Abstract | Full Text A prospective investigation of fish, meat and cooking-related carcinogens with endometrial cancer incidence H Arem, M J Gunter, A J Cross, A R Hollenbeck and R Sinha Br J Cancer 2013 109: 756-760; advance online publication, May 21, 2013; 10.1038/bjc.2013.252 Abstract | Full Text Long-term and baseline recreational physical activity and risk of endometrial cancer: the California Teachers Study C M Dieli-Conwright, H Ma, J V Lacey, Jr, K D Henderson, S Neuhausen, P L Horn-Ross, D Deapen, J Sullivan-Halley and L Bernstein Br J Cancer 2013 109: 761-768; advance online publication, July 16, 2013; 10.1038/bjc.2013.61 Abstract | Full Text Hormonal risk factors and invasive epithelial ovarian cancer risk by parity C Bodelon, N Wentzensen, S J Schonfeld, K Visvanathan, P Hartge, Y Park and R M Pfeiffer Br J Cancer 2013 109: 769-776; advance online publication, July 2, 2013; 10.1038/bjc.2013.344 Abstract | Full Text A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing K A Metcalfe, A Poll, R Royer, S Nanda, M Llacuachaqui, P Sun and S A Narod Br J Cancer 2013 109: 777-779; advance online publication, June 18, 2013; 10.1038/bjc.2013.309 Abstract | Full Text Variation in reported experience of involvement in cancer treatment decision making: evidence from the National Cancer Patient Experience Survey A El Turabi, G A Abel, M Roland and G Lyratzopoulos Br J Cancer 2013 109: 780-787; advance online publication, June 27, 2013; 10.1038/bjc.2013.316 Abstract | Full Text Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma P-Y OuYang, Z Su, Y-P Mao, X-X Liang, Q Liu and F-Y Xie Br J Cancer 2013 109: 788-794; advance online publication, June 27, 2013; 10.1038/bjc.2013.343 Abstract | Full Text Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case–control studies using two primary-care databases Y Vinogradova, C Coupland and J Hippisley-Cox Br J Cancer 2013 109: 795-806; advance online publication, July 18, 2013; 10.1038/bjc.2013.383 Abstract | Full Text Epigenetic alteration: new insights moving from tissue to plasma – the example of PCDH10 promoter methylation in colorectal cancer E Danese, A M Minicozzi, M Benati, M Montagnana, E Paviati, G L Salvagno, M Gusella, F Pasini, G C Guidi and G Lippi Br J Cancer 2013 109: 807-813; advance online publication, July 9, 2013; 10.1038/bjc.2013.351 Abstract | Full Text Lifestyle factors associated with survival after colorectal cancer diagnosis T Boyle, L Fritschi, C Platell and J Heyworth Br J Cancer 2013 109: 814-822; advance online publication, June 20, 2013; 10.1038/bjc.2013.310 Abstract | Full Text Letters to the Editor Top Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality’ – IARC and Chrysotile Risks R A Lemen, A L Frank, C L Soskolne, S H Weiss and B Castleman Br J Cancer 2013 109: 823-825; advance online publication, June 27, 2013; 10.1038/bjc.2013.301 Full Text Reply: Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality’ V McCormack, J Peto, G Byrnes, K Straif and P Boffetta Br J Cancer 2013 109: 825-826; advance online publication, June 27, 2013; 10.1038/bjc.2013.302 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.